Federal subsidies that have helped reduce insurers' costs for Medicare drug plans are set to disappear at the end of 2026. This change could result in millions of Medicare beneficiaries facing higher premiums in 2027 across the United States.

The move, initiated under the Trump administration, marks a significant shift in the funding structure for Medicare drug plans. While the exact impact on individual consumers remains uncertain, the removal of these subsidies is expected to increase out-of-pocket expenses for many.

Sources